• 2011
    • van Geldorp, I. E., Delhaas, T., Gebauer, R. A., Frias, P., Tomaske, M., Friedberg, M. K., Tisma-Dupanovic, S., Elders, J., Fruh, A., Gabbarini, F., Kubus, P., Illikova, V., Tsao, S., Blank, A. C., Hiippala, A., Sluysmans, T., Karpawich, P., Clur, S.-A., Ganame, X., ... Janousek, J. (2011). Impact of the permanent ventricular pacing site on left ventricular function in children: a retrospective multicentre survey. Heart, 97(24), 2051-2055. https://doi.org/10.1136/heartjnl-2011-300197
    • van Loon, R. L. E., Roofthooft, M. T. R., Hillege, H. L., ten Harkel, A. D. J., van Osch-Gevers, M., Delhaas, T., Kapusta, L., Strengers, J. L. M., Rammeloo, L. A. J., Clur, S.-A. B., Mulder, B. J. M., & Berger, R. M. F. (2011). Pediatric Pulmonary Hypertension in the Netherlands Epidemiology and Characterization During the Period 1991 to 2005. Circulation, 124(16), 1755-U136. https://doi.org/10.1161/CIRCULATIONAHA.110.969584
    • Groenveld, H. F., Crijns, H. J. G. M., Van den Berg, M. P., Van Sonderen, E., Alings, A. M., Tijssen, J. G. P., Hillege, H. L., Tuininga, Y. S., van Veldhuisen, D. J., Ranchor, A. V., & Van Gelder, I. C. (2011). The Effect of Rate Control on Quality of Life in Patients With Permanent Atrial Fibrillation Data From the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) Study. Journal of the American College of Cardiology, 58(17), 1795-1803. https://doi.org/10.1016/j.jacc.2011.06.055
    • Bogaard, M. D., Houthuizen, P., Bracke, F. A., Doevendans, P. A., Prinzen, F. W., Meine, M., & van Gelder, B. M. (2011). Baseline left ventricular dP/dt(max) rather than the acute improvement in dP/dt(max) predicts clinical outcome in patients with cardiac resynchronization therapy. European journal of heart failure, 13(10), 1126-1132. https://doi.org/10.1093/eurjhf/hfr094
    • van Almen, G. C., Verhesen, W., van Leeuwen, R. E. W., van de Vrie, M., Eurlings, C., Schellings, M. W. M., Swinnen, M., Cleutjens, J. P. M., van Zandvoort, M. A. M. J., Heymans, S., & Schroen, B. (2011). MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure. Aging Cell, 10(5), 769-779. https://doi.org/10.1111/j.1474-9726.2011.00714.x
    • Weijs, B., Blaauw, Y., Rennenberg, R. J. M. W., Schurgers, L. J., Timmermans, C. C. M. M., Pison, L., Nieuwlaat, R., Hofstra, L., Kroon, A. A., Wildberger, J., & Crijns, H. J. G. M. (2011). Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients. European Heart Journal, 32(20), 2555-2562. https://doi.org/10.1093/eurheartj/ehr226
    • Reilly, S. N., Jayaram, R., Nahar, K., Antoniades, C., Verheule, S., Channon, K. M., Alp, N. J., Schotten, U., & Casadei, B. (2011). Atrial Sources of Reactive Oxygen Species Vary With the Duration and Substrate of Atrial Fibrillation Implications for the Antiarrhythmic Effect of Statins. Circulation, 124(10), 1107-U91. https://doi.org/10.1161/CIRCULATIONAHA.111.029223
    • van Almen, G. C., Swinnen, M., Carai, P., Verhesen, W., Cleutjens, J. P. M., D'hooge, J., Verheyen, F. K., Pinto, Y. M., Schroen, B., Carmeliet, P., & Heymans, S. (2011). Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy. Journal of Molecular and Cellular Cardiology, 51(3), 318-328. https://doi.org/10.1016/j.yjmcc.2011.05.010
    • Linz, D., Schotten, U., Neuberger, H.-R., Boehm, M., & Wirth, K. (2011). Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation. Heart Rhythm, 8(9), 1436-1443. https://doi.org/10.1016/j.hrthm.2011.03.053
    • Heemstra, H. E., Nieuwlaat, R., Meijboom, M., & Crijns, H. J. (2011). The burden of atrial fibrillation in the Netherlands. Netherlands Heart Journal, 19(9), 373-378. https://doi.org/10.1007/s12471-011-0175-4
    • Smit, M. D., Crijns, H. J. G. M., Tijssen, J. G. P., Hillege, H. L., Alings, M., Tuininga, Y. S., Groenveld, H. F., Van den Berg, M. P., van Veldhuisen, D. J., & Van Gelder, I. C. (2011). Effect of Lenient Versus Strict Rate Control on Cardiac Remodeling in Patients With Atrial Fibrillation. Journal of the American College of Cardiology, 58(9), 942-949. https://doi.org/10.1016/j.jacc.2011.04.030
    • Torp-Pedersen, C., Crijns, H. J. G. M., Gaudin, C., Page, R. L., Connolly, S. J., & Hohnloser, S. H. (2011). Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA study. EP Europace, 13(8), 1118-1126. https://doi.org/10.1093/europace/eur102
    • van den Wijngaard, A., Volders, P., van Tintelen, J. P., Jongbloed, J. D. H., van den Berg, M. P., Deprez, R. H. L., Mannens, M. M. A. M., Hofmann, N., van Slegtenhorst, M., Dooijes, D., Michels, M., Arens, Y., Jongbloed, R., & Smeets, B. J. M. (2011). Recurrent and founder mutations in the Netherlands: cardiac Troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathy. Netherlands Heart Journal, 19(7-8), 344-351. https://doi.org/10.1007/s12471-011-0135-z
    • Camm, A. J., Breithardt, G., Crijns, H., Dorian, P., Kowey, P. R., Le Heuzey, J.-Y., Merioua, I., Pedrazzini, L., Prystowsky, E. N., Schwartz, P. J., Torp-Pedersen, C., & Weintraub, W. S. (2011). Real-Life Observations of Clinical Outcomes With Rhythm- and Rate-Control Therapies for Atrial Fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation). Journal of the American College of Cardiology, 58(5), 493-501. https://doi.org/10.1016/j.jacc.2011.03.034
    • Foley, P. W. X., Chalil, S., Ratib, K., Smith, R., Prinzen, F., Auricchio, A., & Leyva, F. (2011). Fluoroscopic Left Ventricular Lead Position and the Long-Term Clinical Outcome of Cardiac Resynchronization Therapy. Pacing and Clinical Electrophysiology, 34(7), 785-797. https://doi.org/10.1111/j.1540-8159.2011.03114.x
    • La Meir, M., Gelsomino, S., Luca, F., Pison, L., Chambille, P., Parise, O., Crijns, H. J., & Maessen, J. G. (2011). Time-Related Prevalence of Postoperative Atrial Fibrillation After Stand-Alone Minimally Invasive Radiofrequency Ablation. Journal of Cardiac Surgery, 26(4), 453-459. https://doi.org/10.1111/j.1540-8191.2011.01272.x
    • Cox, M. G. P. J., van der Zwaag, P. A., van der Werf, C., van der Smagt, J. J., Noorman, M., Bhuiyan, Z. A., Wiesfeld, A. C. P., Volders, P. G. A., van Langen, I. M., Atsma, D. E., Dooijes, D., van den Wijngaard, A., Houweling, A. C., Jongbloed, J. D. H., Jordaens, L. J. L. M., Cramer, M. J., Doevendans, P. A., de Bakker, J. M. T., Wilde, A. A. M., ... Hauer, R. N. W. (2011). Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Pathogenic Desmosome Mutations in Index-Patients Predict Outcome of Family Screening: Dutch Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Genotype-Phenotype Follow-Up Study. Circulation, 123(23), 2690-2700. https://doi.org/10.1161/CIRCULATIONAHA.110.988287
    • Leyva, F., Foley, P. W. X., Chalil, S., Ratib, K., Smith, R. E. A., Prinzen, F., & Auricchio, A. (2011). Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance, 13, 9. https://doi.org/10.1186/1532-429X-13-29
    • Strik, M., Ploux, S., Vernooy, K., & Prinzen, F. W. (2011). Cardiac Resynchronization Therapy - Refocus on the Electrical Substrate. Circulation Journal, 75(6), 1297-1304. https://doi.org/10.1253/circj.CJ-11-0356
    • Postema, P. G., Christiaans, I., Hofman, N., Alders, M., Koopmann, T. T., Bezzina, C. R., Loh, P., Zeppenfeld, K., Volders, P. G. A., & Wilde, A. A. M. (2011). Founder mutations in the Netherlands: familial idiopathic ventricular fibrillation and DPP6. Netherlands Heart Journal, 19(6), 290-296. https://doi.org/10.1007/s12471-011-0102-8
    • Laverty, H. G., Benson, C., Cartwright, E. J., Cross, M. J., Garland, C., Hammond, T. R., Holloway, C., McMahon, N., Milligan, J., Park, B. K., Pirmohamed, M., Pollard, C., Radford, J., Roome, N., Sager, P., Singh, S., Suter, T., Suter, W., Trafford, A. W., ... Valentin, J. P. (2011). How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?British Journal of Pharmacology, 163(4), 675-693. https://doi.org/10.1111/j.1476-5381.2011.01255.x
    • van Geldorp, I. E., Vanagt, W. Y., Prinzen, F. W., & Delhaas, T. (2011). Chronic ventricular pacing in children: toward prevention of pacing-induced heart disease. Heart Failure Reviews, 16(3), 305-314. https://doi.org/10.1007/s10741-010-9207-1
    • Cornelussen, R. N., Splett, V., Klepfer, R. N., Stegemann, B., Kornet, L., & Prinzen, F. W. (2011). Electrical modalities beyond pacing for the treatment of heart failure. Heart Failure Reviews, 16(3), 315-325. https://doi.org/10.1007/s10741-010-9206-2
    • Dinh, T., Baur, L. H. B., Pisters, R., Kamp, O., Verheugt, F. W. A., Smeets, J. L. R. M., Cheriex, E. C., Tieleman, R. G., Prins, M. H., & Crijns, H. J. G. M. (2011). Feasibility of TEE-guided stroke risk assessment in atrial fibrillation-background, aims, design and baseline data of the TIARA pilot study. Netherlands Heart Journal, 19(5), 214-222. https://doi.org/10.1007/s12471-011-0095-3
    • Heijman, J., Volders, P. G. A., Westra, R. L., & Rudy, Y. (2011). Local control of β-adrenergic stimulation: Effects on ventricular myocyte electrophysiology and Ca2+-transient. Journal of Molecular and Cellular Cardiology, 50(5), 863-871. https://doi.org/10.1016/j.yjmcc.2011.02.007
    • Christiaans, I., Birnie, E., Bonsel, G. J., Mannens, M. M. A. M., Michels, M., Majoor-Krakauer, D., Dooijes, D., van Tintelen, J. P., Van den Berg, M. P., Volders, P. G. A., Arens, Y. H., van den Wijngaard, A., Atsma, D. E., Helderman-van den Enden, A. T. J. M., Houweling, A. C., de Boer, K., van der Smagt, J. J., Hauer, R. N. W., Marcelis, C. L. M., ... Wilde, A. A. M. (2011). Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy. European Heart Journal, 32(9), 1161-1170. https://doi.org/10.1093/eurheartj/ehr092
    • Prinzen, F. W., Vernooy, K., DeBoeck, B. W. L., & Delhaas, T. (2011). Mechano-energetics of the asynchronous and resynchronized heart. Heart Failure Reviews, 16(3), 215-224. https://doi.org/10.1007/s10741-010-9205-3
    • el Azzouzi, H., Leptidis, S., Bourajjaj, M., Armand, A.-S., van der Nagel, R., van Bilsen, M., Martins, P. A. D. C., & De Windt, L. J. (2011). Peroxisome Proliferator-activated Receptor (PPAR) Gene Profiling Uncovers Insulin-like Growth Factor-1 as a PPAR alpha Target Gene in Cardioprotection. Journal of Biological Chemistry, 286(16), 14598-14607. https://doi.org/10.1074/jbc.M111.220525
    • Page, R. L., Connolly, S. J., Crijns, H. J. G. M., van Eickels, M., Gaudin, C., Torp-Pedersen, C., & Hohnloser, S. H. (2011). Rhythm- and Rate-Controlling Effects of Dronedarone in Patients With Atrial Fibrillation (from the ATHENA Trial). American Journal of Cardiology, 107(7), 1019-1022. https://doi.org/10.1016/j.amjcard.2010.11.028
    • De Ferrari, G. M., Crijns, H. J. G. M., Borggrefe, M., Milasinovic, G., Smid, J., Zabel, M., Gavazzi, A., Sanzo, A., Dennert, R., Kuschyk, J., Raspopovic, S., Klein, H., Swedberg, K., & Schwartz, P. J. (2011). Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. European Heart Journal, 32(7), 847-855. https://doi.org/10.1093/eurheartj/ehq391
    • Alzand, B. S. N., & Crijns, H. J. G. M. (2011). Diagnostic criteria of broad QRS complex tachycardia: decades of evolution. EP Europace, 13(4), 465-472. https://doi.org/10.1093/europace/euq430
    • van Rijsingen, I. A. W., Bekkers, S. C. A. M., Schalla, S., Hermans-van Ast, J. F., Snoep, G., Alzand, B. S. N., Arens, Y. H. J. M., van den Wijngaard, A., Crijns, H. J. G. M., & Pinto, Y. M. (2011). Exercise related ventricular arrhythmias are related to cardiac fibrosis in hypertrophic cardiomyopathy mutation carriers. Netherlands Heart Journal, 19(4), 168-174. https://doi.org/10.1007/s12471-011-0090-8
    • van de Vrie, M., Heymans, S., & Schroen, B. (2011). MicroRNA Involvement in Immune Activation During Heart Failure. Cardiovascular Drugs and Therapy, 25(2), 161-170. https://doi.org/10.1007/s10557-011-6291-y
    • Kirchhof, P., Kahr, P. C., Kaese, S., Piccini, I., Vokshi, I., Scheld, H.-H., Rotering, H., Fortmueller, L., Laakmann, S., Verheule, S., Schotten, U., Fabritz, L., & Brown, N. A. (2011). PITX2c Is Expressed in the Adult Left Atrium, and Reducing Pitx2c Expression Promotes Atrial Fibrillation Inducibility and Complex Changes in Gene Expression. Circulation : Cardiovascular Genetics, 4(2), 123-U84. https://doi.org/10.1161/CIRCGENETICS.110.958058
    • ACCF/AHA TASK FORCE MEMBERS, & Crijns, H. (2011). 2011 ACCF/AHA/HRS Focused Update on the Management of Patients with Atrial Fibrillation (Update on Dabigatran): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 123(10), 1144-1150. https://doi.org/10.1161/CIR.0b013e31820f14c0
    • Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Le Huezey, J.-Y., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, L. S., Estes, N. A. M. III., Ezekowitz, M. D., Jackman, W. M., January, C. T., Page, R. L., ... Yancy, C. W. (2011). 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines 2006 WRITING COMMITTEE MEMBERS Developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Journal of the American College of Cardiology, 57(11), E101-E198. https://doi.org/10.1016/j.jacc.2010.09.013
    • Wann, L. S., Curtis, A. B., Ellenbogen, K. A., Estes, N. A. M. III., Ezekowitz, M. D., Jackman, W. M., January, C. T., Lowe, J. E., Page, R. L., Slotwiner, D. J., Stevenson, W. G., Tracy, C. M., Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Halperin, J. L., Kay, G. N., Le Heuzey, J.-Y., ... Yancy, C. W. (2011). 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Heart Rhythm, 8(3), E1-E8. https://doi.org/10.1016/j.hrthm.2011.01.032
    • Greiser, M., Lederer, W. J., & Schotten, U. (2011). Alterations of atrial Ca2+ handling as cause and consequence of atrial fibrillation. Cardiovascular Research, 89(4), 722-733. https://doi.org/10.1093/cvr/cvq389
    • Kuijpers, N. H. L., Potse, M., van Dam, P. M., ten Eikelder, H. M. M., Verheule, S., Prinzen, F. W., & Schotten, U. (2011). Mechanoelectrical coupling enhances initiation and affects perpetuation of atrial fibrillation during acute atrial dilation. Heart Rhythm, 8(3), 429-436. https://doi.org/10.1016/j.hrthm.2010.11.020
    • Auricchio, A., & Prinzen, F. W. (2011). Non-Responders to Cardiac Resynchronization Therapy - The Magnitude of the Problem and the Issues. Circulation Journal, 75(3), 521-527. https://doi.org/10.1253/circj.CJ-10-1268
    • Eckstein, J., Maesen, B., Linz, D., Zeemering, S., van Hunnik, A., Verheule, S., Allessie, M., & Schotten, U. (2011). Time course and mechanisms of endo-epicardial electrical dissociation during atrial fibrillation in the goat. Cardiovascular Research, 89(4), 816-824. https://doi.org/10.1093/cvr/cvq336
    • Klimusina, J., De Boeck, B. W. L., Leenders, G. E. H., Faletra, F. F., Prinzen, F., Averaimo, M., Pasotti, E., Klersy, C., Moccetti, T., & Auricchio, A. (2011). Redistribution of left ventricular strain by cardiac resynchronization therapy in heart failure patients. European journal of heart failure, 13(2), 186-194. https://doi.org/10.1093/eurjhf/hfq197
    • Aliot, E., Capucci, A., Crijns, H. J., Goette, A., & Tamargo, J. (2011). Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation. EP Europace, 13(2), 161-173. https://doi.org/10.1093/europace/euq382
    • Wann, L. S., Curtis, A. B., January, C. T., Ellenbogen, K. A., Lowe, J. E., Estes, N. A. M. III., Page, R. L., Ezekowitz, M. D., Slotwiner, D. J., Jackman, W. M., Stevenson, W. G., Tracy, C. M., Fuster, V., Ryden, L. E., Cannom, D. S., Le Heuzey, J.-Y., Crijns, H. J., Olsson, S. B., Prystowsky, E. N., ... Yancy, C. W. (2011). 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology, 57(2), 223-242. https://doi.org/10.1016/j.jacc.2010.10.001
    • ACCF/AHA TASK FORCE MEMBERS, & Crijns, H. (2011). 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 123(1), 104-123. https://doi.org/10.1161/CIR.0b013e3181fa3cf4
    • Sep, S., Rijvers, C., Smits, L., van Bilsen, M., Bekers, O., & Peeters, L. (2011). Early-pregnancy changes in maternal lipid profile in women with recurrent preeclampsia and previously preeclamptic women with normal next pregnancy. Reproductive Sciences, 18(10), 998-1004. https://doi.org/10.1177/1933719111401665
    • Hanssen, S. J. P., Lubbers, T., Hodin, C. M. I., Prinzen, F. W., Buurman, W. A., & Jacobs, M. J. H. M. (2011). Hemolysis results in impaired intestinal microcirculation and intestinal epithelial cell injury. World Journal of Gastroenterology, 17(2), 213-218. https://doi.org/10.3748/wjg.v17.i2.213
    • Amer Coll Cardiology Fdn, & Crijns, H. (2011). 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Heart Rhythm, 8(1), 157-176. https://doi.org/10.1016/j.hrthm.2010.11.047
    • van Geldorp, I. E., Delhaas, T., Hermans, B., Vernooy, K., Broers, B., Klimusina, J., Regoli, F., Faletra, F. F., Moccetti, T., Gerritse, B., Cornelussen, R., Settels, J. J., Crijns, H. J. G. M., Auricchio, A., & Prinzen, F. W. (2011). Comparison of a non-invasive arterial pulse contour technique and echo Doppler aorta velocity-time integral on stroke volume changes in optimization of cardiac resynchronization therapy. EP Europace, 13(1), 87-95. https://doi.org/10.1093/europace/euq348
    • Schotten, U., Verheule, S., Kirchhof, P., & Goette, A. (2011). Pathophysiological Mechanisms of Atrial Fibrillation: A Translational Appraisal. Physiological Reviews, 91(1), 265-325. https://doi.org/10.1152/physrev.00031.2009